<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2023.1210414</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Paternal developmental thyrotoxicosis disrupts neonatal leptin leading to increased adiposity and altered physiology of the melanocortin system</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Martinez</surname>
<given-names>Maria Elena</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Zhaofei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Hernandez</surname>
<given-names>Arturo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/222617"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Center for Molecular Medicine, MaineHealth Institute for Research</institution>, <addr-line>Scarborough, ME</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Graduate School for Biomedical Sciences and Engineering, University of Maine</institution>, <addr-line>Orono, ME</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Medicine, Tufts University School of Medicine</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Jin Young Huh, Sogang University, Republic of Korea</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Gwen V. Childs, University of Arkansas for Medical Sciences, United States; Fernanda Thomazini, Federal University of S&#xe3;o Paulo, Brazil</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Arturo Hernandez, <email xlink:href="mailto:Arturo.Hernandez@mainehealth.org">Arturo.Hernandez@mainehealth.org</email>
</p>
</fn>
<fn fn-type="other" id="fn003">
<p>&#x2020;These authors share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>07</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1210414</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>04</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>07</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Martinez, Wu and Hernandez</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Martinez, Wu and Hernandez</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>The genetic code does not fully explain individual variability and inheritance of susceptibility to endocrine conditions, suggesting the contribution of epigenetic factors acting across generations.</p>
</sec>
<sec>
<title>Methods</title>
<p>We used a mouse model of developmental thyrotoxicosis (<italic>Dio3-/-</italic> mouse) to analyze endocrine outcomes in the adult offspring of <italic>Dio3-/-</italic> males using standard methods for body composition, and baseline and fasting hormonal and gene expression determinations in serum and tissues of relevance to the control of energy balance.</p>
</sec>
<sec>
<title>Results</title>
<p>Compared to controls, adult females with an exposed father (EF females) exhibited higher body weight and fat mass, but not lean mass, a phenotype that was much milder in EF males. After fasting, both EF females and males exhibited a more pronounced decrease in body weight than controls. EF females also showed markedly elevated serum leptin, increased white adipose tissue mRNA expression of leptin and mesoderm-specific transcript but decreased expression of type 2 deiodinase. EF females exhibited decreased serum ghrelin, which showed more pronounced post-fasting changes in EF females than in control females. EF female hypothalami also revealed significant decreases in the expression of pro-opiomelanocortin, agouti-related peptide, neuropeptide <italic>Y</italic> and melanocortin receptor 4. These markers also showed larger changes in response to fasting in EF females than in control females. Adult EF females showed no abnormalities in serum thyroid hormones, but pituitary expression of thyrotropin-releasing hormone receptor 1 and thyroid gland expression of thyroid-stimulating hormone receptor, thyroid peroxidase and iodotyrosine deiodinase were increased at baseline and showed differential regulation after fasting, with no increase in <italic>Trhr1</italic> expression and more pronounced reductions in <italic>Tshr</italic>, <italic>Tpo</italic> and <italic>Iyd</italic>. In EF males, these abnormalities were generally milder. In addition, postnatal day 14 (P14) serum leptin was markedly reduced in EF pups.</p>
</sec>
<sec>
<title>Discussion</title>
<p>A paternal excess of thyroid hormone during development modifies the endocrine programming and energy balance in the offspring in a sexually dimorphic manner, with baseline and dynamic range alterations in the leptin-melanocortin system and thyroid gland, and consequences for adiposity phenotypes. We conclude that thyroid hormone overexposure may have important implications for the non-genetic, inherited etiology of endocrine and metabolic pathologies.</p>
</sec>
</abstract>
<kwd-group>
<kwd>thyroid hormone</kwd>
<kwd>intergenerational epigenetics</kwd>
<kwd>adiposity</kwd>
<kwd>hypothalamic-pituitary-thyroid axis</kwd>
<kwd>fasting</kwd>
<kwd>leptin</kwd>
<kwd>energy balance</kwd>
<kwd>sexual dimorphism</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Institute of Diabetes and Digestive and Kidney Diseases<named-content content-type="fundref-id">10.13039/100000062</named-content>
</contract-sponsor>
<counts>
<fig-count count="10"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="81"/>
<page-count count="14"/>
<word-count count="5598"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Neuroendocrine Science</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>The etiology of complex human conditions, including endocrine and metabolic disorders, is not fully understood. Despite their significant heritability, genetic factors alone cannot explain a large proportion of clinical cases (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B5">5</xref>), suggesting the possibility that intergenerational epigenetic effects (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B6">6</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref>) elicited by environmental circumstances in progenitors or ancestors significantly contribute to the onset or susceptibility to these conditions. In this regard, it is increasingly appreciated that diet (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>), obesity (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>), environmental chemicals (<xref ref-type="bibr" rid="B13">13</xref>) and drugs (<xref ref-type="bibr" rid="B14">14</xref>), hormone levels (<xref ref-type="bibr" rid="B15">15</xref>), infection states (<xref ref-type="bibr" rid="B16">16</xref>), stress and trauma (<xref ref-type="bibr" rid="B17">17</xref>) and social interactions (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>), among other factors, may cause changes in maternal and paternal germ line epigenetic signatures that will lead to phenotypic abnormalities in the offspring and subsequent generations, with broad implications for pathophysiology.</p>
<p>Despite the extensive recent literature on factors that can exert intergenerational epigenetic effects in humans and animal models, we have very limited knowledge of the roles played in this paradigm by the thyroid hormones (<xref ref-type="bibr" rid="B21">21</xref>). Yet the role of aberrant thyroid hormone exposure and signaling in intergenerational epigenetics is of particular importance given the high prevalence of thyroid conditions in humans (<xref ref-type="bibr" rid="B22">22</xref>), including pregnant women, and the ubiquitous presence in our environment of chemicals that can disrupt thyroid hormone physiology (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>).</p>
<p>Recent work has shown that thyroid hormones elicit transgenerational epigenetic effects in humans, as demonstrated by studies on multiple generation descendants of women carrying a mutation in the thyroid hormone receptor beta (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B25">25</xref>). These women experience abnormally elevated thyroid hormone levels during pregnancy, and their genetically normal offspring exhibits a thyroid axis with altered sensitivity to thyroid hormones, a trait that is maintained for at least two generations across the paternal lineage (<xref ref-type="bibr" rid="B15">15</xref>). We have also demonstrated the occurrence of transgenerational epigenetic effects by thyroid hormones using a mouse model of genetic deficiency in the type 3 deiodinase (DIO3), the enzyme that clears both thyroid hormones (<xref ref-type="bibr" rid="B26">26</xref>), thyroxine (T4), and 3,5,3&#x2019;-triiodothyronine (T3), which is considered the active hormone and responsible for canonical signaling due to its highest affinity for the nuclear thyroid hormone receptor (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>). Due to the strong developmental pattern of expression of <italic>Dio3</italic> (<xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B33">33</xref>), mice lacking DIO3 function exhibit pronounced fetal and neonatal thyrotoxicosis (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>) leading to reduced testis size (<xref ref-type="bibr" rid="B32">32</xref>) and decreased methylation in the neonatal testis that in adulthood translates into an aberrant sperm methylome (<xref ref-type="bibr" rid="B36">36</xref>). We have shown that these thyroid hormone-driven alterations in the epigenetic information of the male germ line cause abnormalities in genetically normal F2-generation descendants, affecting neonatal brain gene expression patterns and adult behavior (<xref ref-type="bibr" rid="B36">36</xref>).</p>
<p>However, the seminal work by Bakke in the 70s using rat models of adult hypothyroidism and neonatal thyrotoxicosis (thyroid hormone excess) indicated that animals subjected to these insults produced offspring with abnormal body weight and altered size of several endocrine organs (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). Following on these historic and simple observations, the goal of the present study is to determine the intergenerational effects of thyroid hormones on growth and neuroendocrine physiology using the DIO3-deficiency mouse model of developmental thyrotoxicosis. Thus, here we investigate the energy balance and neuroendocrine phenotypes in the offspring of T3-overexposed males compared to that of animals of the same genotype generated by non-exposed males. Mice from T3-overexposed fathers manifest sexually dimorphic alterations in adiposity, physiological response to fasting and multiple endocrine endpoints of the leptin-melanocortin system and the thyroid axis, suggesting that thyroid hormone states in previous generations are a significant determinant of endocrine and metabolic outcomes.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Experimental animals and animal studies</title>
<p>As a model of developmental overexposure to T3, we used mice genetically deficient in the type 3 deiodinase (DIO3). We have previously described that <italic>Dio3 -/- mice</italic> exhibit markedly elevated serum levels of T3 during fetal and early neonatal life (<xref ref-type="bibr" rid="B34">34</xref>). All experimental mice were on an outbred CD-1 genetic background to overcome the impaired fertility of <italic>Dio3-/-</italic> mice on inbred genetic backgrounds. The original mutant mouse strain was generated in a 129/SvJ genetic background (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B39">39</xref>) and has been backcrossed on a CD-1 background for more than 12 generations. Due to the genomic imprinting and preferential expression of the <italic>Dio3</italic> gene from the paternal allele (<xref ref-type="bibr" rid="B39">39</xref>&#x2013;<xref ref-type="bibr" rid="B41">41</xref>), the colony has been maintained for more than eight generations by crossing wild type males with heterozygous females, so that the heterozygous mice generated for colony maintenance are phenotypically normal, as they carry the <italic>Dio3</italic> mutation in the maternal allele, which is already largely suppressed due to genomic imprinting (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B41">41</xref>). To avoid the influence of confounding factors and minimize biological variability, mothers of experimental animals were mated at two months of age with 2-3 month old males. Experimental animals were born before the mother was four months old. Experimental mice represent only first litters from three to seven different mothers, and litter size was limited to 8-12 pups at birth. Mothers of experimental mice were single-caged before giving birth to avoid paternal effects and a concurrent pregnancy while raising the pups. Animals for adult studies were weaned at the age of three weeks, caged in groups of three or four, and sacrificed at 18-20 weeks of age within the third and fifth hour of the light cycle (~Zeitgeber time 3-5). All mice were maintained on a 12&#xa0;h light/dark cycle, and food (Envigo-Harlan Teklad T.2918.15 for non-breeders and T.2919.10 for breeders) and water were provided <italic>ad libitum</italic>. For fasting experiments, mice were fasted overnight for 16&#xa0;h before euthanasia. Also, some neonatal determinations were performed in mice on a 50/50 mixed 129/SvJ/C57BL/6J genetic background, using the same experimental design. This subset of experimental animals was generated by mating 129/SvJ males of the appropriate genotype with wild type (WT) C57BL/6J females. All mice were euthanized by CO<sub>2</sub> asphyxiation at a rate of 30-50% volume of the euthanasia chamber per minute, according to the guidelines of the American Veterinary Medical Association. Tissues were harvested and immediately frozen on dry ice until further use. All experiments were approved by the MaineHealth Institute for Research Institutional Animal Care and Use Committee (IACUC), under current protocol number 2112.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Experimental design</title>
<p>Experimental mice were generated by crossing <italic>Dio3-/-</italic> males with <italic>Dio3+/+</italic> females (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). We have previously shown that <italic>Dio3-/-</italic> mice are overexposed to T3 during fetal and early neonatal life (<xref ref-type="bibr" rid="B34">34</xref>), and that the neonatal germ cells and adult sperm of <italic>Dio3-/-</italic> males show alterations in DNA methylation (<xref ref-type="bibr" rid="B36">36</xref>). The offspring of these males will be heterozygous for the <italic>Dio3</italic> mutation (<italic>Dio3<sup>m+/p-</sup>)</italic> and will have a mutated paternal <italic>Dio3</italic> allele. To generate suitable control mice, we crossed wild type females with <italic>Dio3<sup>m-/p+</sup>
</italic> males (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). This cross will generate mice of exactly the same genotype (<italic>Dio3<sup>m+/p-</sup>)</italic> as experimental mice, but in this case the father will be phenotypically normal (not overexposed to T3 during development (<xref ref-type="bibr" rid="B40">40</xref>)) as the mutated allele is the maternal one. Thus, both control (non-exposed fathers, NF mice) and experimental mice (exposed fathers, EF mice) had exactly the same genotype and were born to independent wild type females, the only difference between both groups being the T3 overexposure status of the fathers.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Experimental design. Mating diagrams used to generate the mice to study the net effect of paternal T3 overexposure. <italic>Dio3 <sup>-/-</sup>
</italic> mice are overexposed to T3 during fetal and early neonatal life. EF, mice generated by a T3 exposed father; NF, mice generated by non-exposed father. (Not all possible genotypes are shown).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1210414-g001.tif"/>
</fig>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Body composition and serum hormone determinations</title>
<p>Fat and lean mass were measured in isofluorane-anesthetized mice using a Lunar PIXImus II DEXA Densitometer (Fitchburg, WI). During the 5&#xa0;min of this scanning procedure, mice were maintained anesthetized with a constant airflow containing 3% isofluorane and 3% oxygen.</p>
<p>Blood from adult and neonates was collected from the inferior vena cava, allowed to clot at 4 &#xb0;C for at least four hours. After 10 minutes centrifugation at 3000&#xa0;g, serum was taken from the supernatant and stored at -70 &#xb0;C until further used. Serum levels of T3 and T4 were measured in 10 and 1 &#x3bc;l of serum, respectively, as previously described (<xref ref-type="bibr" rid="B42">42</xref>&#x2013;<xref ref-type="bibr" rid="B44">44</xref>) by highly sensitive specific radioimmunoassays using in-house generated antibodies. Serum determinations of leptin, adiponectin and ghrelin were performed using commercially available ELISA kits according to the manufacturer&#x2019;s instructions. Leptin and Adiponectin kits were purchased from R&amp;D Systems (Bio-Techne, Minneapolis, MN, USA); ghrelin kit was purchased from EMD Millipore Corporation (Billerica, MA, USA).</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Real time quantitative PCR</title>
<p>Mouse tissues were harvested and subsequently frozen on dry ice. Total RNA was extracted using the RNeasy kit from Qiagen (Valencia, CA). Total RNA (1 &#xb5;g) was reverse transcribed with M-MLV reverse transcriptase in the presence of random decamers (both from Thermo Fisher Scientific, Waltham, MA) at 65&#xb0;C for 5&#xa0;min, then 37&#xb0;C for 50&#xa0;min. The 20 &#x3bc;l reverse transcription reactions were DNAse treated and diluted by adding 230 &#x3bc;l of RNase free water. An aliquot of each sample was mixed together for an internal standard and diluted fourfold. Real-time PCR reactions were set up in duplicate with gene-specific primers and SYBR Select Master Mix (Thermo Fisher Scientific, Waltham, MA), and run on the CFX Connect from Bio-Rad (Hercules, CA), where they underwent an initial 10&#xa0;min denaturing step, followed by 36 cycles of a denaturing step (94&#xb0;C for 30 s) and an annealing/extension step (60&#xb0;C for 1&#xa0;min). For each individual sample, expression was corrected by the expression of one or more (geometric mean) housekeeping genes (<italic>Gapdh</italic>, <italic>Actb, Ppia or Rn18s)</italic>, if they did not exhibit any significant difference in expression between experimental groups. Expression data are shown in arbitrary units and represented as fold-change over the mean value in the control group, or as fold-change over baseline values for fasting experiments. The sequences of the primers used for each gene determination are shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Statistical analysis</title>
<p>Statistical analyses were performed using the statistical tools of GraphPad Prism 6 (GraphPad Software, Inc.). Given the sexual dimorphisms in body weight and endocrine parameters, adult females and males were analyzed separately. A Student&#x2019;s t-test was used to determine statistical significance at baseline between the two experimental groups. We used one-way ANOVA and Tukey&#x2019;s <italic>post hoc</italic> test to determine statistical significance in comparisons between experimental groups or treatments. Unless otherwise indicated, responses to fasting (gene expression and hormone concentrations) were calculated as a ratio between post-fasting and corresponding baseline values, or as an increment (body composition) between post-fasting and corresponding baseline. Statistical significance was defined as P&lt;0.05. Data are represented as the individual values of independent biological samples and the mean &#xb1; SEM. The number of mice (independent samples) used per experimental group is indicated in each figure and typically varied between 17-22 for baseline body composition, 5-12 for the rest of the adult studies, and 14-23 for neonatal studies.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Body composition and fasting response in mice with T3-overexposed fathers</title>
<p>We examined weight and body composition in mice (EF mice) fathered by males overexposed to T3 during development, and compared them with control mice (NE mice) of the same genotype (see Methods) fathered by phenotypically normal males (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). We observed that EF females showed a marked increase in body weight that was the result of increased adiposity and not of changes in lean mass (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). Compared to control males, EF males did not exhibit significant differences in body weight or lean mass, but we noted a mild increase in fat mass and a significant increase in fat percentage (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Body composition in the female <bold>(A)</bold> and male <bold>(B)</bold> offspring of T3-overexposed (EF) and non-exposed (NF) fathers. Each point represents a different animal. Experimental animals represent four to seven different litters. * and *** indicate P&lt;0.05 and 0.001, respectively, as determined by the Student&#x2019;s t-test (n=17-22).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1210414-g002.tif"/>
</fig>
<p>We subjected a subset of animals to a 16&#xa0;h fasting and determined individual changes in body composition. Both EF and NE female lost total weight after fasting, and this was largely due to a decrease in lean mass, not fat mass (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). However, this post-fasting loss in body weight and lean mass was significantly more pronounced in EF females than in NE females (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). Regarding males, both EF and NF males showed similar reductions in lean mass after fasting (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>), but total body weight loss was larger in EF males (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). This difference, in contrast to females, was accounted for by a lack in fat mass increase, which was noted in NF males (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Body composition changes in response to a 16&#xa0;h fasting. <bold>(A)</bold> Females; <bold>(B)</bold> Males. Data represent the % change vs baseline values. *, ** indicate P&lt;0.05, 0.01, respectively as determined by the Student&#x2019;s t-test (n=7-9).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1210414-g003.tif"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Baseline and fasting response of thyroid axis endpoints</title>
<p>We then investigated hormone levels and gene expression of relevance to the thyroid axis. We observed no differences between EF and NF females in serum levels of T3 and T4 (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). In males, no difference in serum T4 was noted, but EF males showed significantly increased serum T3 (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). After fasting, females and males of both experimental groups manifested a reduction of serum T4 from baseline levels, but this reduction was comparable between EF and NF mice of either sex (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Baseline thyroid hormones and T4 change after fasting. Serum thyroid hormone levels in females <bold>(A)</bold> and males <bold>(B)</bold>; <bold>(C)</bold> Change in T4 after fasting in females and males. * indicate P&lt;0.05 as determined by the Student&#x2019;s t-test (n=7-15).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1210414-g004.tif"/>
</fig>
<p>We measured gene expression in the thyroid gland of markers thyroid-stimulating hormone receptor (<italic>Thsr)</italic>, thyroid peroxidase <italic>(Tpo)</italic> and iodotyrosine deiodinase (<italic>Iyd</italic>). We observed that the expression of all three markers at baseline was significantly elevated in EF females (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>), but significantly decreased in EF males (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). Although the expression of these markers was higher in EF female thyroid glands, their expression after fasting was more pronouncedly reduced from baseline levels than in NF females. (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). In contrast, fasting elicited comparable reductions in the expression of these markers in EF and NF males, and we only noted that <italic>Tpo</italic> fasting response was not as large in EF males as in NF males (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Baseline and post-fasting thyroid gland gene expression. <bold>(A, B)</bold> Baseline gene expression in females <bold>(A)</bold> and males <bold>(B)</bold>; <bold>(C, D)</bold> Post-fasting fold change in gene expression over corresponding baseline values in females <bold>(C)</bold> and males <bold>(D)</bold>. *, **, *** indicate P&lt;0.05, 0.01 and 0.001, respectively as determined by the Student&#x2019;s t-test <bold>(A, B)</bold> or by one-way ANOVA and Tukey&#x2019;s <italic>post hoc</italic> test <bold>(C, D)</bold> (n=7-10).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1210414-g005.tif"/>
</fig>
<p>Pituitary and hypothalamic gene expression did not show major differences between EF and NF females. We observed increased pituitary <italic>Trhr1</italic>expression in EF females, and a slight, not significant, increased in <italic>Tshb</italic> expression but no changes in type 2 deiodinase <italic>(Dio2), Dio3</italic>, or T3 target kruppel-like factor 9 (<italic>Klf9)</italic> (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>). EF females also exhibited decreased hypothalamic expression of thyrptropin-releasing hormone (<italic>Trh)</italic> at baseline, but no differences in the expression of <italic>Dio2, Dio3</italic> or T3-target hairless (<italic>Hr)</italic> (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>). We observed no differences between EF and NF females in the fasting response of pituitary expression of <italic>Klf9, Dio2</italic> or <italic>Dio3</italic>. However, pituitary thyrotropin-releasing hormone receptor 1 (<italic>Trhr1</italic>) expression robustly increased in NF females after fasting, but this response was not observed in EF females (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>). In addition, a post-fasting reduction in pituitary thyroid-stimulating hormone beta chain (<italic>Tshb)</italic> expression was noted in both female groups, but this response was significantly more pronounced in EF females (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>). Regarding hypothalamic expression, we observed a differential response to fasting in the expression of <italic>Dio2</italic> and <italic>Dio3</italic>, while the increased expression of T3-target <italic>Hr</italic> was similar in both groups (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6D</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Female baseline and post-fasting pituitary and hypothalamic expression of thyroid axis genes. <bold>(A, B)</bold> Baseline gene expression in the pituitary <bold>(A)</bold> and hypothalamus <bold>(B)</bold>. <bold>(C, D)</bold> Post-fasting change in gene expression in the pituitary <bold>(C)</bold> and hypothalamus <bold>(D)</bold>. *, **, *** indicate P&lt;0.05, 0.01 and 0.001, respectively as determined by the Student&#x2019;s t-test <bold>(A, B)</bold> or by one-way ANOVA and Tukey&#x2019;s <italic>post hoc</italic> test <bold>(C, D)</bold> (n=7-9).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1210414-g006.tif"/>
</fig>
<p>In males, thyroid axis-related pituitary and hypothalamic expression did not show remarkable differences between EF and NE groups (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1A&#x2013;D</bold>
</xref>). At baseline, pituitary expression of <italic>Dio3</italic> was reduced in EF males, a trend also observed in <italic>Trhr1</italic> expression (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1A</bold>
</xref>), while experimental groups showed no differences in the hypothalamic expression of the genes examined (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1B</bold>
</xref>). After fasting, male pituitary expression of <italic>Dio2, Dio3, Trhr1</italic> and <italic>Tshb</italic> was decreased to different extents compared to baseline levels, but these reductions were similar between EF and NF males (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1C</bold>
</xref>). In the hypothalami of males, fasting elicited minor or no changes in gene expression, and no differential responses were observed between EF and NF males (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1D</bold>
</xref>).</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Baseline and fasting response of leptin-melanocortin system and energy balance endpoints</title>
<p>We also investigated hormone and molecular endpoints of the leptin-melanocortin system that may be associated with the adiposity phenotypes. Consistent with their body composition, serum leptin was markedly elevated in EF females, while we observed no differences in serum adiponectin (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>). After fasting, leptin levels were slightly reduced in both experimental groups of females, but the response was comparable in both experimental groups (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>). Serum adiponectin did not change in either group after fasting (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>). Interestingly, we observed that serum ghrelin, an orexigenic hormone, was significantly reduced at baseline in EF females (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>). After fasting, as expected, serum ghrelin was markedly increased in both experimental groups, but the increase was significantly larger in EF females (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Female baseline and post-fasting serum levels of hormones regulating energy balance. <bold>(A)</bold> Baseline serum hormone levels. <bold>(B)</bold> Fold change in hormone levels in response to 16&#xa0;h fasting. *, *** indicate P&lt;0.05, 0.001, respectively, as determined by the Student&#x2019;s t-test <bold>(A)</bold> or by one-way ANOVA and Tukey&#x2019;s <italic>post hoc</italic> test <bold>(B)</bold> (n=7-9).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1210414-g007.tif"/>
</fig>
<p>We observed no differences between EF and NF males in serum levels of leptin, adiponectin or ghrelin (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2A</bold>
</xref>). However, the post-fasting decrease in serum leptin was significantly more pronounced in EF males than in NF males (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2B</bold>
</xref>). Fasting adiponectin in EF males also trended lower than in NF males, although it did not reach statistical significance (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2A</bold>
</xref>). The changes in serum ghrelin after fasting were large in both groups of males and of similar magnitude.</p>
<p>We then determined the hypothalamic expression of genes related to the leptin-meanocortin system and energy balance. We observed that EF females show significant decreases in the hypothalamic expression of leptin-melanocortin system components, including pro-opiomelanocortin (<italic>Pomc)</italic>, agouti-related peptide <italic>(Agrp)</italic>, neuropeptide Y <italic>(Npy)</italic> and melanocortin receptor 4 (<italic>Mc4r)</italic> (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>), while no differences were noted in the expression of other determinants of energy balance like uncoupling protein 2 (<italic>Ucp2)</italic> and bone morphogenetic protein receptor 1a (<italic>Bmpr1a)</italic>. After overnight fasting, responses relative to their corresponding baselines were significantly more pronounced in EF females, with larger changes in all the markers measured (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>).</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Female baseline and post-fasting hypothalamic expression of energy balance related genes. Baseline <bold>(A)</bold> and post-fasting change <bold>(B)</bold> in hypothalamic gene expression. * and ** indicate P&lt;0.05 and 0.01, respectively, as determined by the Student&#x2019;s t-test <bold>(A)</bold> or by one-way ANOVA and Tukey&#x2019;s <italic>post hoc</italic> test <bold>(B)</bold> (n=8-10).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1210414-g008.tif"/>
</fig>
<p>These results were sexually dimorphic, as they were not observed in EF males. At baseline, hypothalamic expression of all those markers was not different between EF and NF males (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3A</bold>
</xref>). In this regard, fasting responses in EF and NF males were similar for <italic>Pomc, Agrp, Npy</italic> and <italic>Ucp2</italic>, while we observed a modest difference for <italic>Mc4r</italic> and <italic>Bmpr1a</italic>. For these genes, the post-fasting expression levels were slightly different between experimental groups, with their expression values in EF males being higher than in NF males due to an absence of post-fasting decrease or the presence of a post-fasting increase, respectively (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3B</bold>
</xref>).</p>
<p>Given the increased adiposity in EF females, we explored relevant gene expression in white adipose tissue (WAT). Compared to control females, the sub-cutaneous WAT of EF females showed increased expression of adiposity markers mesoderm-specific transcript <italic>(Mest)</italic> and leptin (<italic>Lep</italic>) (the latter did not reach statistical significance), but no differences in the expression of adiponectin (<italic>Adipoq</italic>), adipocyte progenitor marker delta-like non canonical notch ligand 1 (<italic>Dlk1)</italic> or T3-generating, beiging marker <italic>Dio2</italic> (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9A</bold>
</xref>). However, gonadal WAT manifested remarkable changes in gene expression. In this fat depot, adiposity markers <italic>Mest</italic> and <italic>Lep</italic> were strongly up-regulated, while <italic>Dlk1</italic> expression trended higher (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9B</bold>
</xref>). Importantly, we also observed that <italic>Dio2</italic> expression was markedly suppressed in EF gonadal fat, but this decrease was not accompanied by reduced expression of T3 target genes <italic>Klf9, Hr</italic> and glycerol phosphate dehydrogenase 2 (<italic>Gpd2)</italic> (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9B</bold>
</xref>).</p>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>Female gene expression in WAT depots. Gene expression in subcutaneous WAT <bold>(A)</bold> and in gonadal WAT <bold>(B)</bold>. *, **, *** indicate P&lt;0.05, 0.01 and 0.001, respectively as determined by the Student&#x2019;s t-test (n=8-10).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1210414-g009.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Neonatal leptin and T4</title>
<p>We then examine serum levels of leptin and T4 during late neonatal development. At postnatal day 14 (P14), serum leptin was markedly reduced in EF mice compared to NF mice (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10A</bold>
</xref>). The lower leptin in EF mice was comparable to that in their T3-overexposed fathers (<italic>Dio3-/-</italic> males) at the same age, while the higher leptin levels in NF mice were similar to those in genetically intact <italic>Dio3+/+</italic> mice (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10A</bold>
</xref>). At P20, serum levels were significantly higher in EF mice than in NF mice (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10A</bold>
</xref>), suggesting a pronounced disruption in serum leptin ontogeny in EF animals. At P14, we observed no differences in serum adiponectin between EF and NF mice, and values were similar to those in <italic>Dio3+/+</italic> animals (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10B</bold>
</xref>). Similarly, EF, NF and <italic>Dio3+/+</italic> mice showed comparable levels of serum T4 at P14, while values at this age for <italic>Dio3+/+</italic> mice were markedly suppressed (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10C</bold>
</xref>).</p>
<fig id="f10" position="float">
<label>Figure&#xa0;10</label>
<caption>
<p>Postnatal hormone profiles. <bold>(A)</bold> Seum leptin in P14 and P20 mice of both sexes. <bold>(B)</bold> Serum adiponectin in P14 mice of both sexes. <bold>(C)</bold> Serum T4 in P14 mice of both sexes. <bold>(D)</bold> Serum T4 in P5 and P15 mice of both sexes on a mixed 129/SvJ/C57BL/6J genetic background. *** indicate P&lt; 0.001 as determined by the Student&#x2019;s t-test (P20 data) or by one-way ANOVA and Tukey&#x2019;s <italic>post hoc</italic> test (P5, P14 and P15 data) (n=8-27).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1210414-g010.tif"/>
</fig>
<p>Interestingly, using the same experimental design with animals on a 50/50 mixed genetic background (129/SvJ with C57BL/6J, see Methods), we observed that both EF and NF mice have reduced serum T4 compared to <italic>Dio3+/+</italic> mice at P4 (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10D</bold>
</xref>). By P15, we still observed lower serum T4 in EF and NF mice compared to <italic>Dio3+/+</italic> values, but there was a pronounced divergence in serum T4 between EF and NF mice, with the latter trending higher and closer to <italic>Dio3+/+</italic> values, while T4 in EF mice remained strongly suppressed, with values comparable to those in <italic>Dio3-/-</italic> mice (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10D</bold>
</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Mice with global DIO3 deficiency provide a robust, consistent model of fetal and early neonatal thyrotoxicosis (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B40">40</xref>). Using this model, we have recently shown that developmental T3 excess modifies the epigenetic information of the male germ line (<xref ref-type="bibr" rid="B36">36</xref>), with potential consequences for phenotypic alterations in the next generation (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B45">45</xref>). This possibility was supported by seminal work by Bakke using a model of neonatal injections of pharmacological doses of T4 (neo-T4 model) (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Given that DIO3-deficient male (and female) mice exhibit marked alterations in adiposity and in the physiology of the thyroid axis and the leptin-melanocortin system, we investigated those phenotypes in the offspring of DIO3-deficient males.</p>
<p>In contrast to their fathers, which show reduced growth and decreased adiposity (<xref ref-type="bibr" rid="B47">47</xref>), the offspring of <italic>Dio3-/-</italic> males exhibited an increase in body weight in females, but not in males. This observation is consistent with old studies using neo-T4 rats as a model of neonatal thyrotoxicosis, and showing that the female &#x2013;but not male- offspring of neo-T4 males also exhibited elevated body weight (<xref ref-type="bibr" rid="B37">37</xref>). Although that previous study did not provide information about fat mass, in our study, the increased body weight in EF females is largely the result of increased adiposity. Not surprisingly, the obesity phenotype in EF females was associated with a higher level of serum leptin, and with increased WAT expression of <italic>Lep</italic> and <italic>Mest</italic>, two well-established markers of adipose tissue expansion (<xref ref-type="bibr" rid="B48">48</xref>&#x2013;<xref ref-type="bibr" rid="B51">51</xref>). Furthermore, EF female WAT also showed reduced expression of <italic>Dio2</italic>, an enzyme activated by adrenergic stimuli (<xref ref-type="bibr" rid="B52">52</xref>) and that participates in the &#x201c;beiging&#x201d; of adipose tissue (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B54">54</xref>) by locally generating T3 and increasing T3 action (<xref ref-type="bibr" rid="B55">55</xref>). Thus the reduction of <italic>Dio2</italic> suggests a lower metabolic level in the WAT of these females. The more pronounced abnormal gene expression profile in gonadal WAT compared to subcutaneous WAT is consistent with observations of differential physiology of different WAT depots (<xref ref-type="bibr" rid="B56">56</xref>&#x2013;<xref ref-type="bibr" rid="B58">58</xref>).</p>
<p>The obesity phenotype of EF females suggested abnormalities in energy balance that might be a consequence of altered programming of the leptin-melanocortin system, as previously shown for their <italic>Dio3-/-</italic> fathers (<xref ref-type="bibr" rid="B47">47</xref>). Indeed, the decreased baseline expression of hypothalamic leptin-dependent markers <italic>Pomc, Agrp, Npy</italic> and <italic>Mc4r</italic>, as well as their enhanced response to a fasting challenge, indicate an abnormal set-point and a larger dynamic range in the leptin-melanocortin system of EF females, which could be the cause of an abnormal energy balance and obesity. Interestingly, EF females show at baseline lower serum level of ghrelin, an orexigenic peptide (<xref ref-type="bibr" rid="B59">59</xref>), but the change in ghrelin after wasting was much larger, again suggesting an abnormally expanded range in physiological mechanisms affecting feeding.</p>
<p>EF females also exhibited differences in body composition changes after overnight fasting. Although both groups of females lost body weight, EF females lost more weight than controls, and this was largely explained by a more pronounced reduction in lean mass, while fat mass remained at similar levels. As the leptin-melanocortin system has critical role in the physiological response to fasting (<xref ref-type="bibr" rid="B60">60</xref>), the differential sensitivity to fasting in body composition further illustrates the abnormal programming of this system in EF females.</p>
<p>Thyroid hormones are also critical regulators of metabolism and energy balance (<xref ref-type="bibr" rid="B61">61</xref>), and the initial observations by Bakke et&#xa0;al. suggested alterations of the hypothalamic-pituitary-thyroid axis in the offspring of Neo-T4 males (<xref ref-type="bibr" rid="B37">37</xref>). Although we did not observed differences between experimental female groups in serum levels of thyroid hormones at baseline or after fasting, the expression of thyroid markers in EF females thyroid glands was significant increased, an observation that could be consistent with thyroid gland hypertrophy, and with the thyroid gland enlargement previously reported in the female offspring of Neo-T4 males (<xref ref-type="bibr" rid="B37">37</xref>). Although the elevation in pituitary <italic>Tshb</italic> expression in EF females did not reach statistical significance, it was also observed in the female offspring of neo-T4 males (<xref ref-type="bibr" rid="B37">37</xref>), and it could explain the increased expression of thyroid markers as a result of elevated TSH action on the thyroid gland. Still the marked difference in the fasting response of pituitary <italic>Tshb</italic> expression suggests an abnormal physiological programming. Thus, although unchanged thyroid hormone concentrations do not explain the adiposity phenotype, the serum, thyroid gland and pituitary endpoints in EF females all point to an abnormally regulated HPT axis. Although only paraventricular nucleus TRH is hypophysiotropic, the reduced hypothalamic expression of TRH but modest increase in pituitary expression of <italic>Tshb</italic> also suggests altered pituitary sensitivity to TRH, a phenotype that has also been observed in relevant rat (<xref ref-type="bibr" rid="B37">37</xref>) and human (<xref ref-type="bibr" rid="B15">15</xref>) models of paternal thyrotoxicosis.</p>
<p>The abnormal programming of endocrine systems in the offspring of males that experienced T3 excess during development is likely the result of altered epigenetic information in the sperm of these males (<xref ref-type="bibr" rid="B36">36</xref>), leading to disrupted development in the offspring. In this regard, aberrant ontogeny of leptin and thyroid hormones may play a role in the adult phenotypes observed. Serum leptin exhibits a marked peak around P10 in mice (<xref ref-type="bibr" rid="B62">62</xref>), and a large body of literature indicates that this peak exerts important trophic effects in the maturing hypothalamus. Alterations in the neonatal peak of leptin have demonstrated its importance not only for the programming of the hypothalamic melanocortin system and associated feeding and energy balance circuitries (<xref ref-type="bibr" rid="B63">63</xref>&#x2013;<xref ref-type="bibr" rid="B73">73</xref>), but also for the physiology of other hypothalamic-pituitary neuroendocrine systems (<xref ref-type="bibr" rid="B74">74</xref>&#x2013;<xref ref-type="bibr" rid="B76">76</xref>). In this context, the markedly reduced serum leptin manifested by P14 EF mice of both sexes could be indicative of an abnormal leptin profile during neonatal life, and possibly of a blunted leptin peak, which could partially explain the hypothalamic-related phenotypes in adult animals. However, our data represent only one time point and P14, chosen for these initial studies due to thyroid hormones peaking at this time, is not the ideal timing for measuring peak leptin. Thus, demonstration that neonatal leptin abnormalities are indeed causing the adult endocrine phenotypes of EF mice will require more comprehensive studies of neonatal leptin profiles and possible experiments of phenotype rescue by timely neonatal administration of leptin. In this regard, changes in neonatal leptin profiles have also been previously associated with the intergenational effects of maternal nutrition status in a sheep model (<xref ref-type="bibr" rid="B77">77</xref>). Interestingly, the reduced neonatal leptin in EF mice is comparable to that in their <italic>Dio3-/-</italic> fathers, suggesting a paternal epigenetic transmission of neonatal leptin phenotypes.</p>
<p>Developmental alterations in serum thyroid hormones could also be contributing to the adult phenotypes of EF mice. For example, neonatal excess in T3 levels, as that observed in <italic>Dio3-/-</italic> mice and neo-T4 rats, also influences the programming of HPT axis and leptin-melanocortin system (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B79">79</xref>). Low neonatal levels of thyroid hormone can also determine hypothalamic leptin signaling in adult life (<xref ref-type="bibr" rid="B80">80</xref>). However, we observed no alterations in that regard. P14 levels of T4 in EF mice were the same as in the NF control group and in <italic>Dio3+/+</italic> mice, even though we observed a marked excess-T3 suppresion of serum T4 in their <italic>Dio3-/-</italic> fathers, consistent with previous reports (<xref ref-type="bibr" rid="B34">34</xref>). It is still possible that alterations in serum thyroid hormones occur in the EF mice studied at earlier ages and are then normalized by P14. This possibility is illustrated by the results we obtained from mice on a different genetic background. On a mixed C57BL/6J/129/SvJ genetic background serum T4 in P4 EF mice is strongly suppressed to a comparable degree to that in <italic>Dio3-/-</italic> mice. At this age NF mice also exhibit a milder T4 suppresion. T4 remains suppressed by P14 in EF mice and partially normalizes in NF mice, suggesting a pattern of normalization with late neonatal development, and opening the possibility that the adult phenotypes identified in our main experiment are also partly the result of aberrant thyroid hormone levels in early life. These results also suggest the severity of some T3-induced intergenerational epigenetic effects is dependent on the genetic background of the animals, a notion that has been noted in other paradigms of intergenerational effects (<xref ref-type="bibr" rid="B81">81</xref>).</p>
<p>Although the phenotypes observed in EF males are milder than those in females, their percentage of body fat, body composition response to fasting, thyroid gland markers and post-fasting leptin, to name a few parameters, are still significantly abnormal, also suggesting an endocrine programming different from controls that could potentially affect other physiological systems, or be more overtly revealed by other types of physiological challenges. Considering the likely developmental origins of the phenotypes observed, as discussed above, the sexual dimorphism in adult outcomes may be the result of leptin and thyroid hormone cross-talk with mechanisms of hypothalamic sexual differentiation during neonatal life.</p>
<p>In summary, our results demonstrate that paternal alterations in thyroid hormone states may cause broad effects in the neuroendocrine physiology of the offspring, affecting their susceptibility to obesity and endocrine disease. These outcomes likely develop from aberrant neonatal leptin or other hormones as a result of the altered epigenetic information that is transmitted <italic>via</italic> the sperm of fathers overexposed to T3. In humans, this paradigm may have important implications for susceptibility to endocrine disease in children whose fathers were exposed to excessive T3 signaling while <italic>in utero</italic> due to maternal thyroid disease.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was reviewed and approved by MaineHealth Institute for Research Instituional Animal Care and Use Committee.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>MEM and ZW performed all the experiments, generated and analyzed data, and drafted results and figures. AH designed the study and wrote the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This research was funded by grant DK095908 from the US National Institute for Diabetes, Digestive and Kidney Diseases. This work utilized the Molecular Phenotyping and the Physiology Core Facilities at MaineHealth Institute for Research. These core facilities are partly supported by grants P30GM106391, U54GM115516, and P20GM121301 from the National Institute of General Medical Sciences.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We are grateful to Jean Jamo for thoughtful support with animal care and husbandry.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2023.1210414/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2023.1210414/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trerotola</surname> <given-names>M</given-names>
</name>
<name>
<surname>Relli</surname> <given-names>V</given-names>
</name>
<name>
<surname>Simeone</surname> <given-names>P</given-names>
</name>
<name>
<surname>Alberti</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Epigenetic inheritance and the missing heritability</article-title>. <source>Hum Genomics</source> (<year>2015</year>) <volume>9</volume>:<fpage>17</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40246-015-0041-3</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>The curse of the missing heritability</article-title>. <source>Front Genet</source> (<year>2013</year>) <volume>4</volume>:<elocation-id>225</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fgene.2013.00225</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manolio</surname> <given-names>TA</given-names>
</name>
</person-group>. <article-title>Finding the missing heritability of complex diseases</article-title>. <source>Nature</source> (<year>2009</year>) <volume>461</volume>:<page-range>747&#x2013;53</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature08494</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemminki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Forsti</surname> <given-names>A</given-names>
</name>
<name>
<surname>Houlston</surname> <given-names>R</given-names>
</name>
<name>
<surname>Bermejo</surname> <given-names>JL</given-names>
</name>
</person-group>. <article-title>Searching for the missing heritability of complex diseases</article-title>. <source>Hum Mutat</source> (<year>2011</year>) <volume>32</volume>:<page-range>259&#x2013;62</page-range>. doi: <pub-id pub-id-type="doi">10.1002/humu.21392</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Wray</surname> <given-names>NR</given-names>
</name>
<name>
<surname>Goddard</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Visscher</surname> <given-names>PM</given-names>
</name>
</person-group>. <article-title>Estimating missing heritability for disease from genome-wide association studies</article-title>. <source>Am J Hum Genet</source> (<year>2011</year>) <volume>88</volume>(<issue>3</issue>):<fpage>294</fpage>&#x2013;<lpage>305</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.02.002</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koch</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Epigenetics: an epigenetic twist on the missing heritability of complex traits</article-title>. <source>Nat Rev Genet</source> (<year>2014</year>) <volume>15</volume>:<fpage>218</fpage>. doi: <pub-id pub-id-type="doi">10.1038/nrg3698</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koch</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Disease genetics: insights into missing heritability</article-title>. <source>Nat Rev Genet</source> (<year>2014</year>) <volume>15</volume>:<fpage>218</fpage>. doi: <pub-id pub-id-type="doi">10.1101/2023.06.07.23291095</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lempradl</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Germ cell-mediated mechanisms of epigenetic inheritance</article-title>. <source>Semin Cell Dev Biol</source> (<year>2020</year>) <volume>97</volume>:<page-range>116&#x2013;22</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.semcdb.2019.07.012</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jimenez-Chillaron</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Isganaitis</surname> <given-names>E</given-names>
</name>
<name>
<surname>Charalambous</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gesta</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pentinat-Pelegrin</surname> <given-names>T</given-names>
</name>
<name>
<surname>Faucette</surname> <given-names>RR</given-names>
</name>
<etal/>
</person-group>. <article-title>Intergenerational transmission of glucose intolerance and obesity by in <italic>utero</italic> undernutrition in mice</article-title>. <source>Diabetes</source> (<year>2009</year>) <volume>58</volume>:<page-range>460&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.2337/db08-0490</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rachdaoui</surname> <given-names>N</given-names>
</name>
<name>
<surname>Sarkar</surname> <given-names>DK</given-names>
</name>
</person-group>. <article-title>Transgenerational epigenetics and brain disorders</article-title>. <source>Int Rev Neurobiol</source> (<year>2014</year>) <volume>115</volume>:<fpage>51</fpage>&#x2013;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1016/B978-0-12-801311-3.00002-0</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Bixler</surname> <given-names>BJ</given-names>
</name>
<name>
<surname>Ruiz</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>HL</given-names>
</name>
<name>
<surname>Lisenbaum</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xiang</surname> <given-names>J-F</given-names>
</name>
<etal/>
</person-group>. <article-title>Transgenerational inheritance of BPA-induced obesity correlates with transmission of new CTCF sites in the Fto gene</article-title>. <source>bioRxiv</source> (<year>2020</year>) <volume>2020</volume>:<elocation-id>2020.11.20.391672</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/2020.11.20.391672</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palu</surname> <given-names>RAS</given-names>
</name>
<name>
<surname>Praggastis</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Thummel</surname> <given-names>CS</given-names>
</name>
</person-group>. <article-title>Parental obesity leads to metabolic changes in the F2 generation in Drosophila</article-title>. <source>Mol Metab</source> (<year>2017</year>) <volume>6</volume>:<page-range>631&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.molmet.2017.03.012</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skinner</surname> <given-names>MK</given-names>
</name>
</person-group>. <article-title>Endocrine disruptors in 2015: Epigenetic transgenerational inheritance</article-title>. <source>Nat Rev Endocrinol</source> (<year>2016</year>) <volume>12</volume>:<fpage>68</fpage>&#x2013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrendo.2015.206</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>HV</given-names>
</name>
<name>
<surname>Forestier</surname> <given-names>S</given-names>
</name>
<name>
<surname>Corces</surname> <given-names>VG</given-names>
</name>
</person-group>. <article-title>Exposure to sevoflurane results in changes of transcription factor occupancy in sperm and inheritance of autism&#x2020;</article-title>. <source>Biol Reprod</source> (<year>2021</year>) <volume>105</volume>:<page-range>705&#x2013;19</page-range>. doi: <pub-id pub-id-type="doi">10.1093/biolre/ioab097</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anselmo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Scherberg</surname> <given-names>NH</given-names>
</name>
<name>
<surname>Dumitrescu</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Refetoff</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Reduced sensitivity to thyroid hormone as a transgenerational epigenetic marker transmitted along the human male line</article-title>. <source>Thyroid Off J Am Thyroid Assoc</source> (<year>2019</year>) <volume>29</volume>:<page-range>778&#x2013;82</page-range>. doi: <pub-id pub-id-type="doi">10.1089/thy.2019.0080</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weaver</surname> <given-names>IC</given-names>
</name>
</person-group>. <article-title>Integrating early life experience, gene expression, brain development, and emergent phenotypes: unraveling the thread of nature <italic>via</italic> nurture</article-title>. <source>Adv Genet</source> (<year>2014</year>) <volume>86</volume>:<fpage>277</fpage>&#x2013;<lpage>307</lpage>. doi: <pub-id pub-id-type="doi">10.1016/B978-0-12-800222-3.00011-5</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jawaid</surname> <given-names>A</given-names>
</name>
<name>
<surname>Roszkowski</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mansuy</surname> <given-names>IM</given-names>
</name>
</person-group>. <article-title>Transgenerational epigenetics of traumatic stress</article-title>. <source>Prog Mol Biol Transl Sci</source> (<year>2018</year>) <volume>158</volume>:<page-range>273&#x2013;98</page-range>. doi: <pub-id pub-id-type="doi">10.1016/bs.pmbts.2018.03.003</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yeshurun</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hannan</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>Transgenerational epigenetic influences of paternal environmental exposures on brain function and predisposition to psychiatric disorders</article-title>. <source>Mol Psychiatry</source> (<year>2019</year>) <volume>24</volume>:<page-range>536&#x2013;48</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41380-018-0039-z</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bale</surname> <given-names>TL</given-names>
</name>
</person-group>. <article-title>Epigenetic and transgenerational reprogramming of brain development</article-title>. <source>Nat Rev Neurosci</source> (<year>2015</year>) <volume>16</volume>:<page-range>332&#x2013;44</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nrn3818</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weaver</surname> <given-names>IC</given-names>
</name>
<name>
<surname>Cervoni</surname> <given-names>N</given-names>
</name>
<name>
<surname>Champagne</surname> <given-names>FA</given-names>
</name>
<name>
<surname>D'Alessio</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Seckl</surname> <given-names>JR</given-names>
</name>
<etal/>
</person-group>. <article-title>Epigenetic programming by maternal behavior</article-title>. <source>Nat Neurosci</source> (<year>2004</year>) <volume>7</volume>:<page-range>847&#x2013;54</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nn1276</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Chaves</surname> <given-names>C</given-names>
</name>
<name>
<surname>Anselmo</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Epigenetic developmental programming and intergenerational effects of thyroid hormones</article-title>. <source>Vitamins hormones</source> (<year>2023</year>) <volume>122</volume>:<fpage>23</fpage>&#x2013;<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.1016/bs.vh.2023.01.003</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLachlan</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Nagayama</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Rapoport</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Insight into Graves' hyperthyroidism from animal models</article-title>. <source>Endocrine Rev</source> (<year>2005</year>) <volume>26</volume>:<page-range>800&#x2013;32</page-range>. doi: <pub-id pub-id-type="doi">10.1210/er.2004-0023</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramh&#xf8;j</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hass</surname> <given-names>U</given-names>
</name>
<name>
<surname>Gilbert</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>C</given-names>
</name>
<name>
<surname>Svingen</surname> <given-names>T</given-names>
</name>
<name>
<surname>Usai</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Evaluating thyroid hormone disruption: investigations of long-term neurodevelopmental effects in rats after perinatal exposure to perfluorohexane sulfonate (PFHxS)</article-title>. <source>Sci Rep</source> (<year>2020</year>) <volume>10</volume>:<fpage>2672</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-020-59354-z</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Souza</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Kizys</surname> <given-names>MM</given-names>
</name>
<name>
<surname>da Concei&#xe7;&#xe3;o</surname> <given-names>RR</given-names>
</name>
<name>
<surname>Glebocki</surname> <given-names>G</given-names>
</name>
<name>
<surname>Romano</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Ortiga-Carvalho</surname> <given-names>TM</given-names>
</name>
<etal/>
</person-group>. <article-title>Perinatal exposure to glyphosate-based herbicide alters the thyrotrophic axis and causes thyroid hormone homeostasis imbalance in male rats</article-title>. <source>Toxicology</source> (<year>2017</year>) <volume>377</volume>:<fpage>25</fpage>&#x2013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tox.2016.11.005</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anselmo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chaves</surname> <given-names>CM</given-names>
</name>
</person-group>. <article-title>Physiologic significance of epigenetic regulation of thyroid hormone target gene expression</article-title>. <source>Eur Thyroid J</source> (<year>2020</year>) <volume>9</volume>:<page-range>114&#x2013;23</page-range>. doi: <pub-id pub-id-type="doi">10.1159/000506423</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Structure and function of the type 3 deiodinase gene</article-title>. <source>Thyroid</source> (<year>2005</year>) <volume>15</volume>:<page-range>865&#x2013;74</page-range>. doi: <pub-id pub-id-type="doi">10.1089/thy.2005.15.865</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Leonard</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>PJ</given-names>
</name>
</person-group>. <article-title>Molecular aspects of thyroid hormone actions</article-title>. <source>Endocrine Rev</source> (<year>2010</year>) <volume>31</volume>:<page-range>139&#x2013;70</page-range>. doi: <pub-id pub-id-type="doi">10.1210/er.2009-0007</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brent</surname> <given-names>GA</given-names>
</name>
</person-group>. <article-title>Mechanisms of thyroid hormone action</article-title>. <source>J Clin Invest</source> (<year>2012</year>) <volume>122</volume>:<page-range>3035&#x2013;43</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI60047</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Dorfman</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Genest</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Salvatore</surname> <given-names>D</given-names>
</name>
<name>
<surname>Larsen</surname> <given-names>PR</given-names>
</name>
</person-group>. <article-title>Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2003</year>) <volume>88</volume>:<page-range>1384&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1210/jc.2002-021291</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galton</surname> <given-names>VA</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>E</given-names>
</name>
<name>
<surname>Hernandez</surname> <given-names>A</given-names>
</name>
<name>
<surname>St Germain</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Bates</surname> <given-names>JM</given-names>
</name>
<name>
<surname>St Germain</surname> <given-names>DL</given-names>
</name>
</person-group>. <article-title>Pregnant rat uterus expresses high levels of the type 3 iodothyronine deiodinase</article-title>. <source>J Clin Invest</source> (<year>1999</year>) <volume>103</volume>:<page-range>979&#x2013;87</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI6073</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaplan</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Yaskoski</surname> <given-names>KA</given-names>
</name>
</person-group>. <article-title>Maturational patterns of iodothyronine phenolic and tyrosyl ring deiodinase activities in rat cerebrum, cerebellum, and hypothalamus</article-title>. <source>J Clin Invest</source> (<year>1981</year>) <volume>67</volume>:<page-range>1208&#x2013;14</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI110136</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Karaczyn</surname> <given-names>A</given-names>
</name>
<name>
<surname>Stohn</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Donnelly</surname> <given-names>WT</given-names>
</name>
<name>
<surname>Croteau</surname> <given-names>W</given-names>
</name>
<name>
<surname>Peeters</surname> <given-names>RP</given-names>
</name>
<etal/>
</person-group>. <article-title>The type 3 deiodinase is a critical determinant of appropriate thyroid hormone action in the developing testis</article-title>. <source>Endocrinology</source> (<year>2016</year>) <volume>157</volume>:<page-range>1276&#x2013;88</page-range>. doi: <pub-id pub-id-type="doi">10.1210/en.2015-1910</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Ng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Forrest</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Thyroid hormone deiodinases: dynamic switches in developmental transitions</article-title>. <source>Endocrinology</source> (<year>2021</year>) <volume>162</volume>(<issue>8</issue>):<page-range>1&#x2013;15</page-range>. doi: <pub-id pub-id-type="doi">10.1210/endocr/bqab091</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Fiering</surname> <given-names>S</given-names>
</name>
<name>
<surname>Galton</surname> <given-names>VA</given-names>
</name>
<name>
<surname>St Germain</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Type 3 deiodinase is critical for the maturation and function of the thyroid axis</article-title>. <source>J Clin Invest</source> (<year>2006</year>) <volume>116</volume>:<page-range>476&#x2013;84</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI26240</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Hernandez</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>The type 3 deiodinase is a critical modulator of thyroid hormone sensitivity in the fetal brain</article-title>. <source>Front Neurosci</source> (<year>2021</year>) <volume>15</volume>:<page-range>703&#x2013;30</page-range>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2021.703730</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Duarte</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Stohn</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Karaczyn</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>DeMambro</surname> <given-names>VE</given-names>
</name>
<etal/>
</person-group>. <article-title>Thyroid hormone influences brain gene expression programs and behaviors in later generations by altering germ line epigenetic information</article-title>. <source>Mol Psychiatry</source> (<year>2020</year>) <volume>25</volume>:<page-range>939&#x2013;50</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41380-018-0281-4</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakke</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Lawrence</surname> <given-names>NL</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bennett</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Endocrine studies in the untreated F1 and F2 progeny of rats treated neonatally with thyroxine Biol</article-title>. <source>Neonate</source> (<year>1977</year>) <volume>31</volume>:<fpage>71</fpage>&#x2013;<lpage>83</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000240946</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakke</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Lawrence</surname> <given-names>NL</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bennett</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Observations on the untreated progeny of hypothyroid male rats</article-title>. <source>Metabolism: Clin Exp</source> (<year>1976</year>) <volume>25</volume>:<page-range>437&#x2013;44</page-range>. doi: <pub-id pub-id-type="doi">10.1016/0026-0495(76)90076-7</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Fiering</surname> <given-names>S</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>E</given-names>
</name>
<name>
<surname>Galton</surname> <given-names>VA</given-names>
</name>
<name>
<surname>St Germain</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>The gene locus encoding iodothyronine deiodinase type 3 (Dio3) is imprinted in the fetus and expresses antisense transcripts</article-title>. <source>Endocrinology</source> (<year>2002</year>) <volume>143</volume>:<page-range>4483&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1210/en.2002-220800</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Charalambous</surname> <given-names>M</given-names>
</name>
<name>
<surname>Saferali</surname> <given-names>A</given-names>
</name>
<name>
<surname>Fiering</surname> <given-names>S</given-names>
</name>
<name>
<surname>Naumova</surname> <given-names>AK</given-names>
</name>
<name>
<surname>St Germain</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Genomic imprinting variations in the mouse type 3 deiodinase gene between tissues and brain regions</article-title>. <source>Mol Endocrinol (Baltimore Md.)</source> (<year>2014</year>) <volume>28</volume>:<page-range>1875&#x2013;86</page-range>. doi: <pub-id pub-id-type="doi">10.1210/me.2014-1210</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Ito</surname> <given-names>M</given-names>
</name>
<name>
<surname>Takagi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Takada</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ferguson-Smith</surname> <given-names>AC</given-names>
</name>
</person-group>. <article-title>Genomic imprinting contributes to thyroid hormone metabolism in the mouse embryo</article-title>. <source>Curr Biol</source> (<year>2002</year>) <volume>12</volume>:<page-range>1221&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0960-9822(02)00951-X</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gil-Ibanez</surname> <given-names>P</given-names>
</name>
<name>
<surname>Belinchon</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Morte</surname> <given-names>B</given-names>
</name>
<name>
<surname>Obregon</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Bernal</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Is the intrinsic genomic activity of thyroxine relevant <italic>in vivo</italic>? Effects on gene expression in primary cerebrocortical and neuroblastoma cells</article-title>. <source>Thyroid Off J Am Thyroid Assoc</source> (<year>2017</year>) <volume>27</volume>:<page-range>1092&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1089/thy.2017.0024</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>B&#xe1;rez-L&#xf3;pez</surname> <given-names>S</given-names>
</name>
<name>
<surname>Obregon</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Mart&#xed;nez-de-Mena</surname> <given-names>R</given-names>
</name>
<name>
<surname>Bernal</surname> <given-names>J</given-names>
</name>
<name>
<surname>Guada&#xf1;o-Ferraz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Morte</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Effect of triiodothyroacetic acid treatment in mct8 deficiency: A word of caution</article-title>. <source>Thyroid</source> (<year>2016</year>) <volume>26</volume>:<page-range>618&#x2013;26</page-range>. doi: <pub-id pub-id-type="doi">10.1089/thy.2015.0388</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Escobar-Morreale</surname> <given-names>HF</given-names>
</name>
<name>
<surname>Obregon</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Hernandez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Escobar del Rey</surname> <given-names>F</given-names>
</name>
<name>
<surname>Morreale de Escobar</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Regulation of iodothyronine deiodinase activity as studied in thyroidectomized rats infused with thyroxine or triiodothyronine</article-title>. <source>Endocrinology</source> (<year>1997</year>) <volume>138</volume>:<page-range>2559&#x2013;68</page-range>. doi: <pub-id pub-id-type="doi">10.1210/endo.138.6.5212</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Stohn</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Mutina</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Whitten</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Hernandez</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Thyroid hormone elicits intergenerational epigenetic effects on adult social behavior and fetal brain expression of autism susceptibility genes</article-title>. <source>Front Neurosci</source> (<year>2022</year>) <volume>16</volume>:<elocation-id>1055116</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2022.1055116</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakke</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Lawrence</surname> <given-names>N</given-names>
</name>
<name>
<surname>Wilber</surname> <given-names>JF</given-names>
</name>
</person-group>. <article-title>The late effects of neonatal hyperthyroidism upon the hypothalamic-pituitary-thyroid axis in the rat</article-title>. <source>Endocrinology</source> (<year>1974</year>) <volume>95</volume>:<page-range>406&#x2013;11</page-range>. doi: <pub-id pub-id-type="doi">10.1210/endo-95-2-406</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>ME</given-names>
</name>
<name>
<surname>St Germain</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Hernandez</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Type 3 deiodinase role on central thyroid hormone action affects the leptin-melanocortin system and circadian activity</article-title>. <source>Endocrinology</source> (<year>2017</year>) <volume>158</volume>:<page-range>419&#x2013;30</page-range>. doi: <pub-id pub-id-type="doi">10.1210/en.2016-1680</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedman</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>20 years of leptin: leptin at 20: an overview</article-title>. <source>J Endocrinol</source> (<year>2014</year>) <volume>223</volume>:<page-range>T1&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1530/JOE-14-0405</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedman</surname> <given-names>JM</given-names>
</name>
</person-group>. <article-title>The function of leptin in nutrition, weight, and physiology</article-title>. <source>Nutr Rev</source> (<year>2002</year>) <volume>60</volume>:<fpage>S1</fpage>&#x2013;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1301/002966402320634878</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anunciado-Koza</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Manuel</surname> <given-names>J</given-names>
</name>
<name>
<surname>Mynatt</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kozak</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Koza</surname> <given-names>RA</given-names>
</name>
</person-group>. <article-title>Diet-induced adipose tissue expansion is mitigated in mice with a targeted inactivation of mesoderm specific transcript (Mest)</article-title>. <source>PloS One</source> (<year>2017</year>) <volume>12</volume>:<elocation-id>e0179879</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0179879</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anunciado-Koza</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Higgins</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Koza</surname> <given-names>RA</given-names>
</name>
</person-group>. <article-title>Adipose tissue Mest and Sfrp5 are concomitant with variations of adiposity among inbred mouse strains fed a non-obesogenic diet</article-title>. <source>Biochimie</source> (<year>2016</year>) <volume>124</volume>:<page-range>134&#x2013;40</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.biochi.2015.05.007</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fonseca</surname> <given-names>TL</given-names>
</name>
<name>
<surname>Werneck-de-Castro</surname> <given-names>JPS</given-names>
</name>
<name>
<surname>Bianco</surname> <given-names>AC</given-names>
</name>
</person-group>. <article-title>Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling</article-title>. <source>Biochim Biophys Acta</source> (<year>2013</year>) <volume>1830</volume>:<page-range>3956&#x2013;64</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.bbagen.2012.08.019</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Shon</surname> <given-names>DH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Ryu</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>SAMM50 regulates thermogenesis of beige adipocytes differentiated from human adipose-derived stem cells by balancing mitochondrial dynamics</article-title>. <source>Int J Mol Sci</source> (<year>2022</year>) <volume>23</volume>(<issue>12</issue>):<fpage>6764</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms23126764</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ju</surname> <given-names>L</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Alimujiang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>N</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>H</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>A novel role for Bcl2l13 in promoting beige adipocyte biogenesis</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2018</year>) <volume>506</volume>:<page-range>485&#x2013;91</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2018.10.034</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>JZ</given-names>
</name>
<name>
<surname>Martag&#xf3;n</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Cimini</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Gonzalez</surname> <given-names>DD</given-names>
</name>
<name>
<surname>Tinkey</surname> <given-names>DW</given-names>
</name>
<name>
<surname>Biter</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Pharmacological activation of thyroid hormone receptors elicits a functional conversion of white to brown fat</article-title>. <source>Cell Rep</source> (<year>2015</year>) <volume>13</volume>:<page-range>1528&#x2013;37</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2015.10.022</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narita</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kobayashi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Itakura</surname> <given-names>K</given-names>
</name>
<name>
<surname>Itagawa</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kabaya</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sudo</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Differential response to caloric restriction of retroperitoneal, epididymal, and subcutaneous adipose tissue depots in rats</article-title>. <source>Exp gerontology</source> (<year>2018</year>) <volume>104</volume>:<page-range>127&#x2013;37</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.exger.2018.01.016</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wronska</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kmiec</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Structural and biochemical characteristics of various white adipose tissue depots</article-title>. <source>Acta physiologica (Oxford England)</source> (<year>2012</year>) <volume>205</volume>:<fpage>194</fpage>&#x2013;<lpage>208</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1748-1716.2012.02409.x</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sackmann-Sala</surname> <given-names>L</given-names>
</name>
<name>
<surname>Berryman</surname> <given-names>DE</given-names>
</name>
<name>
<surname>Munn</surname> <given-names>RD</given-names>
</name>
<name>
<surname>Lubbers</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Kopchick</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>Heterogeneity among white adipose tissue depots in male C57BL/6J mice</article-title>. <source>Obes (Silver Spring Md.)</source> (<year>2012</year>) <volume>20</volume>:<page-range>101&#x2013;11</page-range>. doi: <pub-id pub-id-type="doi">10.1038/oby.2011.235</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrews</surname> <given-names>ZB</given-names>
</name>
</person-group>. <article-title>Central mechanisms involved in the orexigenic actions of ghrelin</article-title>. <source>Peptides</source> (<year>2011</year>) <volume>32</volume>:<page-range>2248&#x2013;55</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.peptides.2011.05.014</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caron</surname> <given-names>A</given-names>
</name>
<name>
<surname>Dungan Lemko</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Castorena</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Fujikawa</surname> <given-names>T</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lord</surname> <given-names>CC</given-names>
</name>
<etal/>
</person-group>. <article-title>POMC neurons expressing leptin receptors coordinate metabolic responses to fasting <italic>via</italic> suppression of leptin levels</article-title>. <source>eLife</source> (<year>2018</year>) <volume>7</volume>:<page-range>1&#x2013;18</page-range>. doi: <pub-id pub-id-type="doi">10.7554/eLife.33710</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bianco</surname> <given-names>AC</given-names>
</name>
</person-group>. <article-title>Minireview: cracking the metabolic code for thyroid hormone signaling</article-title>. <source>Endocrinology</source> (<year>2011</year>) <volume>152</volume>:<page-range>3306&#x2013;11</page-range>. doi: <pub-id pub-id-type="doi">10.1210/en.2011-1104</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouret</surname> <given-names>SG</given-names>
</name>
<name>
<surname>Simerly</surname> <given-names>RB</given-names>
</name>
</person-group>. <article-title>Development of leptin-sensitive circuits</article-title>. <source>J Neuroendocrinol</source> (<year>2007</year>) <volume>19</volume>:<page-range>575&#x2013;82</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2826.2007.01563.x</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouret</surname> <given-names>SG</given-names>
</name>
<name>
<surname>Simerly</surname> <given-names>RB</given-names>
</name>
</person-group>. <article-title>Minireview: Leptin and development of hypothalamic feeding circuits</article-title>. <source>Endocrinology</source> (<year>2004</year>) <volume>145</volume>:<page-range>2621&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1210/en.2004-0231</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Djiane</surname> <given-names>J</given-names>
</name>
<name>
<surname>Attig</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Role of leptin during perinatal metabolic programming and obesity</article-title>. <source>J Physiol Pharmacol</source> (<year>2008</year>) <volume>59 Suppl 1</volume>:<fpage>55</fpage>&#x2013;<lpage>63</lpage>.</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toste</surname> <given-names>FP</given-names>
</name>
<name>
<surname>de Moura</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Lisboa</surname> <given-names>PC</given-names>
</name>
<name>
<surname>Fagundes</surname> <given-names>AT</given-names>
</name>
<name>
<surname>de Oliveira</surname> <given-names>E</given-names>
</name>
<name>
<surname>Passos</surname> <given-names>MC</given-names>
</name>
</person-group>. <article-title>Neonatal leptin treatment programmes leptin hypothalamic resistance and intermediary metabolic parameters in adult rats</article-title>. <source>Br J Nutr</source> (<year>2006</year>) <volume>95</volume>:<page-range>830&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1079/BJN20061726</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vickers</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Gluckman</surname> <given-names>PD</given-names>
</name>
<name>
<surname>Coveny</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Hofman</surname> <given-names>PL</given-names>
</name>
<name>
<surname>Cutfield</surname> <given-names>WS</given-names>
</name>
<name>
<surname>Gertler</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Neonatal leptin treatment reverses developmental programming</article-title>. <source>Endocrinology</source> (<year>2005</year>) <volume>146</volume>:<page-range>4211&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1210/en.2005-0581</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mela</surname> <given-names>V</given-names>
</name>
<name>
<surname>Jimenez</surname> <given-names>S</given-names>
</name>
<name>
<surname>Freire-Regatillo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Barrios</surname> <given-names>V</given-names>
</name>
<name>
<surname>Marco</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Lopez-Rodriguez</surname> <given-names>AB</given-names>
</name>
<etal/>
</person-group>. <article-title>Blockage of neonatal leptin signaling induces changes in the hypothalamus associated with delayed pubertal onset and modifications in neuropeptide expression during adulthood in male rats</article-title>. <source>Peptides</source> (<year>2016</year>) <volume>86</volume>:<fpage>63</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.peptides.2016.10.003</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeltser</surname> <given-names>LM</given-names>
</name>
</person-group>. <article-title>Developmental influences on circuits programming susceptibility to obesity</article-title>. <source>Front Neuroendocrinol</source> (<year>2015</year>) <volume>39</volume>:<fpage>17</fpage>&#x2013;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.yfrne.2015.07.002</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouyer</surname> <given-names>K</given-names>
</name>
<name>
<surname>Simerly</surname> <given-names>RB</given-names>
</name>
</person-group>. <article-title>Neonatal leptin exposure specifies innervation of presympathetic hypothalamic neurons and improves the metabolic status of leptin-deficient mice</article-title>. <source>J Neurosci Off J Soc Neurosci</source> (<year>2013</year>) <volume>33</volume>:<page-range>840&#x2013;51</page-range>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3215-12.2013</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beltrand</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sloboda</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Connor</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Truong</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vickers</surname> <given-names>MH</given-names>
</name>
</person-group>. <article-title>The Effect of Neonatal Leptin Antagonism in Male Rat Offspring Is Dependent upon the Interaction between Prior Maternal Nutritional Status and Post-Weaning Diet</article-title>. <source>J Nutr Metab</source> (<year>2012</year>) <volume>2012</volume>:<fpage>296935</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2012/296935</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Granado</surname> <given-names>M</given-names>
</name>
<name>
<surname>Garcia-Caceres</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fuente-Martin</surname> <given-names>E</given-names>
</name>
<name>
<surname>Diaz</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mela</surname> <given-names>V</given-names>
</name>
<name>
<surname>Viveros</surname> <given-names>MP</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of acute changes in neonatal leptin levels on food intake and long-term metabolic profiles in rats</article-title>. <source>Endocrinology</source> (<year>2011</year>) <volume>152</volume>:<page-range>4116&#x2013;26</page-range>. doi: <pub-id pub-id-type="doi">10.1210/en.2011-1233</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gluckman</surname> <given-names>PD</given-names>
</name>
<name>
<surname>Lillycrop</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Vickers</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Pleasants</surname> <given-names>AB</given-names>
</name>
<name>
<surname>Phillips</surname> <given-names>ES</given-names>
</name>
<name>
<surname>Beedle</surname> <given-names>AS</given-names>
</name>
<etal/>
</person-group>. <article-title>Metabolic plasticity during mammalian development is directionally dependent on early nutritional status</article-title>. <source>Proc Natl Acad Sci United States America</source> (<year>2007</year>) <volume>104</volume>:<page-range>12796&#x2013;800</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0705667104</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dutra</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Moura</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Rodrigues</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Lisboa</surname> <given-names>PC</given-names>
</name>
<name>
<surname>Bonomo</surname> <given-names>I</given-names>
</name>
<name>
<surname>Toste</surname> <given-names>FP</given-names>
</name>
<etal/>
</person-group>. <article-title>Cold exposure restores the decrease in leptin receptors (OB-Rb) caused by neonatal leptin treatment in 30-day-old rats</article-title>. <source>J Endocrinol</source> (<year>2007</year>) <volume>195</volume>:<page-range>351&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1677/JOE-07-0366</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Childs</surname> <given-names>GV</given-names>
</name>
<name>
<surname>Odle</surname> <given-names>AK</given-names>
</name>
<name>
<surname>MacNicol</surname> <given-names>MC</given-names>
</name>
<name>
<surname>MacNicol</surname> <given-names>AM</given-names>
</name>
</person-group>. <article-title>The importance of leptin to reproduction</article-title>. <source>Endocrinology</source> (<year>2021</year>) <volume>162</volume>(<issue>2</issue>):<page-range>1&#x2013;18</page-range>. doi: <pub-id pub-id-type="doi">10.1210/endocr/bqaa204</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Odle</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Allensworth-James</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Akhter</surname> <given-names>N</given-names>
</name>
<name>
<surname>Syed</surname> <given-names>M</given-names>
</name>
<name>
<surname>Haney</surname> <given-names>AC</given-names>
</name>
<name>
<surname>MacNicol</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Tropic role for leptin in the somatotrope as a regulator of POU1F1 and POU1F1-dependent hormones</article-title>. <source>Endocrinology</source> (<year>2016</year>) <volume>157</volume>:<page-range>3958&#x2013;71</page-range>. doi: <pub-id pub-id-type="doi">10.1210/en.2016-1472</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proulx</surname> <given-names>K</given-names>
</name>
<name>
<surname>Clavel</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nault</surname> <given-names>G</given-names>
</name>
<name>
<surname>Richard</surname> <given-names>D</given-names>
</name>
<name>
<surname>Walker</surname> <given-names>CD</given-names>
</name>
</person-group>. <article-title>High neonatal leptin exposure enhances brain GR expression and feedback efficacy on the adrenocortical axis of developing rats</article-title>. <source>Endocrinology</source> (<year>2001</year>) <volume>142</volume>:<page-range>4607&#x2013;16</page-range>. doi: <pub-id pub-id-type="doi">10.1210/endo.142.11.8512</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shasa</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Odhiambo</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Long</surname> <given-names>NM</given-names>
</name>
<name>
<surname>Tuersunjiang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Nathanielsz</surname> <given-names>PW</given-names>
</name>
<name>
<surname>Ford</surname> <given-names>SP</given-names>
</name>
</person-group>. <article-title>Multigenerational impact of maternal overnutrition/obesity in the sheep on the neonatal leptin surge in granddaughters (2005)</article-title>. <source>Int J Obes</source> (<year>2015</year>) <volume>39</volume>:<fpage>695</fpage>&#x2013;<lpage>701</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ijo.2014.190</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakke</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Lawrence</surname> <given-names>N</given-names>
</name>
<name>
<surname>Wilber</surname> <given-names>JF</given-names>
</name>
</person-group>. <article-title>The late effects of neonatal hyperthyoridism upon the hypothalamic-pituitary-thyroid axis in the rat</article-title>. <source>Endocrinology</source> (<year>1974</year>) <volume>95</volume>:<page-range>406&#x2013;11</page-range>. doi: <pub-id pub-id-type="doi">10.1210/endo-95-2-406</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez</surname> <given-names>A</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>XH</given-names>
</name>
<name>
<surname>Van Sande</surname> <given-names>J</given-names>
</name>
<name>
<surname>Refetoff</surname> <given-names>S</given-names>
</name>
<name>
<surname>Galton</surname> <given-names>VA</given-names>
</name>
<etal/>
</person-group>. <article-title>Type 3 deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis</article-title>. <source>Endocrinology</source> (<year>2007</year>) <volume>148</volume>:<page-range>5680&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1210/en.2007-0652</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tapia-Mart&#xed;nez</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cano-Europa</surname> <given-names>E</given-names>
</name>
<name>
<surname>Blas-Valdivia</surname> <given-names>V</given-names>
</name>
<name>
<surname>Franco-Col&#xed;n</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Thyroxine treatment during the perinatal stage prevents the alterations in the obRb-STAT3 leptin signaling pathway caused by congenital hypothyroidism</article-title>. <source>Hormone Metab Res = Hormon- und Stoffwechselforschung = Hormones metabolisme</source> (<year>2020</year>) <volume>52</volume>:<page-range>815&#x2013;21</page-range>. doi: <pub-id pub-id-type="doi">10.1055/a-1160-9833</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname> <given-names>KN</given-names>
</name>
<name>
<surname>Zimmel</surname> <given-names>KN</given-names>
</name>
<name>
<surname>Roach</surname> <given-names>AN</given-names>
</name>
<name>
<surname>Basel</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mehta</surname> <given-names>NA</given-names>
</name>
<name>
<surname>Bedi</surname> <given-names>YS</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal background alters the penetrance of growth phenotypes and sex-specific placental adaptation of offspring sired by alcohol-exposed males</article-title>. <source>FASEB J</source> (<year>2021</year>) <volume>35</volume>:<elocation-id>e22035</elocation-id>. doi: <pub-id pub-id-type="doi">10.1096/fj.202101131R</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>